Stuart Phillis

455 total citations
6 papers, 295 citations indexed

About

Stuart Phillis is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Stuart Phillis has authored 6 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Hematology and 3 papers in Rheumatology. Recurrent topics in Stuart Phillis's work include Chronic Lymphocytic Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Stuart Phillis is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Stuart Phillis collaborates with scholars based in Australia and United States. Stuart Phillis's co-authors include Timothy P. Hughes, Bronte A. Jamison, David M. Ross, Susan Branford, David T Yeung, Alexandra L. Yeoman, Haley Altamura, John F. Seymour, Andrew Grigg and Nicola D. Roberts and has published in prestigious journals such as Blood and Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin.

In The Last Decade

Stuart Phillis

6 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart Phillis Australia 5 258 223 126 65 52 6 295
Bronte A. Jamison Australia 5 307 1.2× 262 1.2× 148 1.2× 51 0.8× 41 0.8× 5 327
Alexandra L. Yeoman Australia 5 310 1.2× 263 1.2× 149 1.2× 51 0.8× 42 0.8× 6 330
Haley Altamura Australia 6 382 1.5× 319 1.4× 178 1.4× 73 1.1× 49 0.9× 8 408
Nataliia Glushko Ukraine 2 275 1.1× 217 1.0× 120 1.0× 28 0.4× 77 1.5× 2 327
María Soledad Undurraga Chile 4 425 1.6× 361 1.6× 212 1.7× 43 0.7× 71 1.4× 9 460
Arta Dreimane Sweden 9 296 1.1× 246 1.1× 123 1.0× 45 0.7× 74 1.4× 17 347
Lucy C. Crossman United States 4 283 1.1× 241 1.1× 169 1.3× 35 0.5× 19 0.4× 6 317
Juan Julio Kassack Ipiña Mexico 4 418 1.6× 366 1.6× 210 1.7× 41 0.6× 81 1.6× 5 471
M. C. Muller Germany 7 288 1.1× 235 1.1× 161 1.3× 43 0.7× 26 0.5× 7 350
Greg Malnassy United States 6 143 0.6× 118 0.5× 75 0.6× 58 0.9× 73 1.4× 10 254

Countries citing papers authored by Stuart Phillis

Since Specialization
Citations

This map shows the geographic impact of Stuart Phillis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Phillis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Phillis more than expected).

Fields of papers citing papers by Stuart Phillis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Phillis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Phillis. The network helps show where Stuart Phillis may publish in the future.

Co-authorship network of co-authors of Stuart Phillis

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Phillis. A scholar is included among the top collaborators of Stuart Phillis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Phillis. Stuart Phillis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Yeung, David T, Wendy T Parker, Stuart Phillis, et al.. (2015). BCR-ABL Assay Sensitivity of MR4.5 Achieved in >90%, and MR5 in >75% of Samples, through mRNA Selection before qRT-PCR. Blood. 126(23). 2777–2777. 2 indexed citations
3.
Branford, Susan, David T Yeung, Wendy T Parker, et al.. (2014). Prognosis for patients with CML and >10% BCR-ABL1 after 3 months of imatinib depends on the rate of BCR-ABL1 decline. Blood. 124(4). 511–518. 136 indexed citations
4.
Branford, Susan, David T Yeung, David M. Ross, et al.. (2013). Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib discontinuation in patients with CML. Blood. 121(19). 3818–3824. 121 indexed citations
5.
Branford, Susan, David M. Ross, Haley Altamura, et al.. (2012). Early Molecular Response and Female Sex Strongly Predict Achievement of Stable Undetectable BCR-ABL1, a Criterion for Imatinib Discontinuation in Patients with CML. Blood. 120(21). 165–165. 5 indexed citations
6.
Moore, James W., Gregory J. Goodall, Michelle Thomas, et al.. (2009). Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 454(3). 291–302. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026